ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Avalo Therapeutics Inc

Avalo Therapeutics Inc (AVTX)

15.94
0.96
(6.41%)
Closed April 27 4:00PM
15.40
-0.54
(-3.39%)
After Hours: 7:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
15.94
Bid
15.35
Ask
16.15
Volume
78,226
14.69 Day's Range 16.225
3.9501 52 Week Range 1,130.40
Market Cap
Previous Close
14.98
Open
15.00
Last Trade
1
@
16
Last Trade Time
Financial Volume
$ 1,201,775
VWAP
15.3629
Average Volume (3m)
716,683
Shares Outstanding
801,611
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-39.35
Revenue
1.92M
Net Profit
-31.54M

About Avalo Therapeutics Inc

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Avalo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTX. The last closing price for Avalo Therapeutics was $14.98. Over the last year, Avalo Therapeutics shares have traded in a share price range of $ 3.9501 to $ 1,130.40.

Avalo Therapeutics currently has 801,611 shares outstanding. The market capitalization of Avalo Therapeutics is $2.35 million. Avalo Therapeutics has a price to earnings ratio (PE ratio) of -0.07.

AVTX Latest News

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avalo’s recent acquisition of...

Avalo Reports 2023 Financial Results and Provides Business Updates

Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront...

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed...

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company’s common stock, par value...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.2636.472602739711.6816.3211.468412713.47377887CS
4-3.06-16.10526315791922.4711.130440416.1004492CS
1211.33245.7700650764.6134.464.010171668319.34684681CS
26-9.98-38.503086419825.9234.463.95011122307418.03156162CS
52-696.86-97.7637485971712.81130.43.95012358624733.37290335CS
156-672.86-97.6858304297688.81711.23.9501897605539.32072394CS
260-672.86-97.6858304297688.81711.23.9501897605539.32072394CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

AVTX Discussion

View Posts
Brooge warrants cancelled Brooge warrants cancelled 3 weeks ago
?????
👍️0
Meangene818 Meangene818 3 weeks ago
$35 next week??
👍️0
retireat40 retireat40 4 weeks ago
Uh…
👍️0
Monksdream Monksdream 4 weeks ago
AVTX over $20
Next day settlement begins 5/28 per SEC mandate
👍️0
Speculator gipsy Speculator gipsy 4 weeks ago
Crystal ball glowing green
👍️0
glens0 glens0 4 weeks ago
No worry what I'm hearing is more upside coming. AVTX was trading at $1130 last June.
👍️0
glens0 glens0 4 weeks ago
Hearing a lot more coming here. Last June $1130.00 Micro Float.... 700k
👍️0
da_stock_analyst da_stock_analyst 4 weeks ago
#AVTX 🔥 huge move and ready for next week? $avtx
👍️0
retireat40 retireat40 4 weeks ago
Nope
👍️0
Moonboy1 Moonboy1 4 weeks ago
I took a chance and bought at $20. But missed a 50% profit due to no day trades left. Was hoping it would hold at least $25 for Monday. Oh well. Will be lucky to get out at $15 Monday morning in my opinion.
👍️0
Pt3 Pt3 4 weeks ago
Same no daytrade stuck at 23
👍️0
Roadtojourney Roadtojourney 4 weeks ago
Yes.
👍️0
tonyjh tonyjh 4 weeks ago
Was this CERC?
👍️0
Moonboy1 Moonboy1 4 weeks ago
I'm stuck with this until Monday at 7 am. Out of day trades so hope it holds.
👍️0
gapole gapole 4 weeks ago
just broke 30..do i hear 35??
👍️0
Invest-in-America Invest-in-America 4 weeks ago
AVTX: And ya sold way too EARLY, Dude!!!
👍️0
gapole gapole 4 weeks ago
AVTX..over 26 mvg again for ph
👍️0
Stockexpertpro Stockexpertpro 4 weeks ago
BCG Wow AVTX What a move!
👍️0
Moonboy1 Moonboy1 4 weeks ago
Another holo? Congrats for the holders here. Will be interesting watching people chase this and lose their a--
👍️0
Roadtojourney Roadtojourney 4 weeks ago
As per per, They are getting $115 million upfront payment that will go beyond 2027. And someone mentioned the float is 800k.
👍️0
PennyPusher786 PennyPusher786 1 month ago
Although if you multiply by the peak price at the beginning of winter of about .25 cents... that's like $60.... and .12-.13 where it was mostly at is more like a $30 mark and a break even for many... so... I wouldn't get excited yet
👍️0
PennyPusher786 PennyPusher786 1 month ago
Finally a chance to get out with sizeable returns lol... and hopefully it doesn't tank in the morning and instead runs to 30+ ahaha

👍️0
apr1 apr1 1 month ago
Holy smokes! I bought 200 shares of this at 4.91 last Friday and just sold at 22.50 for a sweet 460% profit. That doesn’t happen often. 973$ to 4,500$ in 2 hours.
👍️ 3
TIMGZ TIMGZ 1 month ago
ELECTION IS COMING
👍️0
Invest-in-America Invest-in-America 1 month ago
AVTX: So there goes ALL of our trading theories, down the toilet!!! (Now it's grab them any time, & flip them any time!!!)
👍️0
TIMGZ TIMGZ 1 month ago
400 PERCCEEEENT
👍️0
Invest-in-America Invest-in-America 1 month ago
AVTX: A 6-bagger for sure, even before the looming Open!!!
👍️0
Awl416 Awl416 1 month ago
Wild
👍️0
surf1944 surf1944 1 month ago
https://stockcharts.com/h-sc/ui?s=avtx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/avtx/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/avtx/opinion

https://finance.yahoo.com/quote/avtx/

Short sell!
👍️0
TheFinalCD TheFinalCD 1 month ago
NO WAY

LL
👍️0
Awl416 Awl416 1 month ago
Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 Million
👍️0
TheFinalCD TheFinalCD 1 month ago
$avtx 11.11 NEWS https://ir.avalotx.com/press-releases/detail/183/avalo-acquires-anti-il-1-mab-and-announces-private

https://finviz.com/quote.ashx?t=AVTX&p=d

Cash Position

The company has -2.7 months of cash left based on quarterly cash burn of -$9.3M and estimated current cash of $-8.4M.
https://dilutiontracker.com/app/search/AVTX
👍️0
Monksdream Monksdream 1 month ago
AVTX 10Qndueb3/18
👍️0
Monksdream Monksdream 2 months ago
AVTX 10Q March 11
👍️0
Monksdream Monksdream 2 months ago
AVTX 10Q March 4
👍️0
oldstocks oldstocks 2 months ago
RespireRx Pharmaceuticals RSPI $ KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/
👍️0
oldstocks oldstocks 2 months ago
CERECOR in September 2016 acquired right to Anti Epilepsy Drug LY3130481 from Eli Lilly Cerecor branded drug CERC-611
Cerecor and Aevi Genomic Medicine Merged Feb 2020
Cerecor rebranded into Avalo Therapeutics ticker AVTX
Avalo Therapeutics (formerly Cerecor) is developing AVTX 611 (formerly CERC 611)
November 2022 Avalo Therapeutics enters into an agreement with ES Therapeutics to sell its net economic rights to future payments of previously out-licensed assets including CERC 611
AVTX 611 got rebranded to ES 481 is being developed by ES Therapeutics for the treatment of Epilepsy.
Clinical development is underway in Australia and Canada.
Study Design
Total Participants: 24
Study Start date:
November 21, 2021
Estimated Completion Date:
December 31, 2023

This webpage mentions:
The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81
https://www.sciencedirect.com/science/article/abs/pii/S000689931930410X




The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81
Abstract
The need for improved antiepileptics is clearly mandated despite the existence of multiple existing medicines from different chemical and mechanistic classes. Standard of care agents do not fully control epilepsies and have a variety of side-effect and safety issues. Patients typically take multiple antiepileptic drugs and yet many continue to have seizures. Antiepileptic-unresponsive seizures are life-disrupting and life-threatening. One approach to seizure control is surgical resection of affected brain tissue and associated neural circuits. Although non-human brain studies can provide insight into novel antiepileptic mechanisms, human epileptic brain is the bottom-line biological substrate. Human epileptic brain can provide definitive information on the presence or absence of the putative protein targets of interest in the patient population, the potential changes in these proteins in the epileptic state, and the engagement of novel molecules and their functional impact in target tissue. In this review, we discuss data on two novel potential antiepileptic drugs. CERC-611 (LY3130481) is an AMPA receptor antagonist that selectively blocks AMPA receptors associated with the auxiliary protein TARP ?-8 and is in clinical development. KRM-II-81 is a positive allosteric modulator of GABAA receptors selectively associated with protein subunits a2 and a 3. Preclinical data on these compounds argue that patient-based biological data increase the probability that a newly discovered molecule will translate its antiepileptic potential to patients.
👍️0
Meangene818 Meangene818 3 months ago
May grab some today. Could be making the turn now
👍️0
PennyPusher786 PennyPusher786 3 months ago
It's possible
👍️0
PennyPusher786 PennyPusher786 3 months ago
Dammmmn down from $1000 in July to $5.... suddenly I have more faith in AMC lol
👍️0
Meangene818 Meangene818 3 months ago
Hmmmmm!!
👍️0
DeafTrader2 DeafTrader2 4 months ago
www.zacks.com STRONG BUY #1 wowza
👍️0
Stockexpertpro Stockexpertpro 4 months ago
45 Million Dollar Milestone payment and over 10 Million in cash no debt This could push cash over 50$ per share waiting for data tiny float now after massive 240 for 1 RS
👍️0
m_m007 m_m007 4 months ago
Back below a dollar in 2024
👍️0
colorfullife88200 colorfullife88200 4 months ago
For shareholders best interest ? tomorrow is the day ! 1 for 240 RS !!! Most wipe out , You make money by trading , they make $$ by RS ....right ?
👍️0
ErnieBilco ErnieBilco 4 months ago
Dirtbags changed ratio to 240 to 1 and moved the date to the 29th - just doesn't get much more pinkish than this group of clowns.
👍️0
ErnieBilco ErnieBilco 4 months ago
Ouchhhhheeee 250 to 1 RS tomorrow - the illusion of being a real company continues with a stolen pps increase by theft.
👍️0
peanutz peanutz 4 months ago
23 million on the ask ? Really
👍️0
peanutz peanutz 4 months ago
Pre market boom is happening !
👍️0
peanutz peanutz 4 months ago
That's why I'm in this . The float is tiny and you are right, it will be untradable . Damn shame for sure .
👍️0

Your Recent History

Delayed Upgrade Clock